Literature DB >> 3899027

Presidential address: Tumoribus praeter naturam.

E M Bricker.   

Abstract

Mesh:

Year:  1985        PMID: 3899027      PMCID: PMC1250894          DOI: 10.1097/00000658-198509000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  17 in total

1.  RESULTS OF SIMPLIFIED TREATMENT OF BREAST CANCER.

Authors:  G CRILE
Journal:  Surg Gynecol Obstet       Date:  1964-03

2.  Tumors of the testis.

Authors:  J F PATTON; N MALLIS
Journal:  J Urol       Date:  1959-03       Impact factor: 7.450

3.  The Stanford medical linear accelerator. III. Application to clinical problems of radiation therapy.

Authors:  H S KAPLAN; M A BAGSHAW
Journal:  Stanford Med Bull       Date:  1957-08

4.  Defining the surgical oncologist.

Authors:  R E Wilson
Journal:  Bull Am Coll Surg       Date:  1984-07

5.  Breast Adjuvant Chemotherapy: Effectiveness of Thio-Tepa (Triethylenethiophosphoramide) as Adjuvant to Radical Mastectomy for Breast Cancer.

Authors: 
Journal:  Ann Surg       Date:  1961-10       Impact factor: 12.969

6.  CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY.

Authors:  C D Haagensen; A P Stout
Journal:  Ann Surg       Date:  1943-11       Impact factor: 12.969

7.  Bladder substitution after pelvic evisceration.

Authors:  E M BRICKER
Journal:  Surg Clin North Am       Date:  1950-10       Impact factor: 2.741

8.  [The contraceptive pill and vascular accidents].

Authors:  M Lancet
Journal:  Harefuah       Date:  1983-02-01

9.  The evolution of therapeutic research in cancer.

Authors:  V T DeVita
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

10.  Pelvic exenteration for locally advanced colorectal carcinoma.

Authors:  J Boey; J Wong; G B Ong
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

View more
  1 in total

1.  Science, specialization, and the American Surgical Association.

Authors:  C F Barker
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.